Clinical Trials Directory

Trials / Completed

CompletedNCT01116505

Treatment of Screen-detected Celiac Disease

Treatment of Screen-detected Celiac Disease in Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Tampere University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to evaluate the natural history of celiac disease in asymptomatic, screen-detected subjects having positive endomysial antibodies and the effects of an intervention with a gluten-free diet. The investigators hypothesize that these subjects may have decreased general health and benefit of the dietary treatment regardless of the small-bowel mucosal structure.

Detailed description

Asymptomatic, endomysial-antibody positive adults will be randomized to either continue with a normal, gluten-containing diet or start an intervention with a gluten-free diet irrespective of the small-bowel mucosal morphology. Several celiac-disease associated histological, serological and clinical markers will be evaluated both at baseline and after one year on trial.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGluten-free dietgluten-containing cereals removed from diet

Timeline

Start date
2008-08-01
Primary completion
2012-07-01
Completion
2012-08-01
First posted
2010-05-05
Last updated
2012-08-27

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01116505. Inclusion in this directory is not an endorsement.